^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MRX34

    i
    Other names: MRX34, miR-Rx34, miR-RX34 liposome injectable suspension, miR-34 mimic, liposomal miR-34a mimic, liposomal mimic of microRNA-34a
    Associations

    News

    Trials
    Company:
    Synlogic
    Drug class:
    Bcl2 inhibitor, c-MET inhibitor, β-catenin inhibitor, MYC inhibitor
    Related drugs:
    Associations

    News

    Trials
    3years
    Functional and Clinical Significance of Dysregulated microRNAs in Liver Cancer. (PubMed, Cancers (Basel))
    Clinical treatment drugs have been developed based on miR-34 and miR-122 (MRX34 and Miravirsen, respectively), but their side effects have not yet been overcome. Future research is needed to address these weaknesses and establish a feasible microRNA-based treatment strategy for liver cancer.
    Clinical • Review • Journal
    |
    MIR21 (MicroRNA 21) • MIR34A (MicroRNA 34a-5p) • MIR122 (MicroRNA 122) • MIR214 (MicroRNA 214)
    |
    MRX34